Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of pitavastatin calcium intermediate

A technology of pitavastatin calcium and intermediates, applied in the field of drug synthesis, can solve the problems of affecting the total yield of products, product instability, consumption of large alkaline water, etc., and achieve simple post-processing of products, simple post-processing, and avoiding decomposition Effect

Inactive Publication Date: 2021-01-05
江苏阿尔法集团福瑞药业(宿迁)有限公司
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Although this route is better in terms of yield and cost, due to the use of phosphorus tribromide as the bromination agent in the reaction process, it is necessary to use alkaline water to quench phosphorus tribromide after the reaction, which will consume a large amount of Alkaline water, and produce a large amount of waste water containing bromine and phosphorus; at the same time, brominated intermediates will be affected by acid-base conditions during the quenching process, resulting in unstable products and affecting the total yield of the final product. Therefore, under the increasing pressure of environmental protection Grim now, the route's advantage is being lost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of pitavastatin calcium intermediate
  • Preparation method of pitavastatin calcium intermediate
  • Preparation method of pitavastatin calcium intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Add 40ml of toluene, 10g (0.034mol) 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinemethanol (N7) and 7.28g (0.041mol) NBS in the reaction flask, under nitrogen protection Under certain conditions, stir and raise the temperature to 50°C, and keep the temperature for 6 hours to prepare the intermediate product compound N8.1, without separation, directly add 10.29g (0.039mol) triphenylphosphine to the obtained reaction solution, stir and heat up to 70°C , keep the reaction for 6 hours, then lower the temperature to 0°C, stir and crystallize for 1 hour, centrifuge, and dry to obtain 19.75g of the product [[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl ]Methyl]triphenylphosphorous chloride (N8.2), yield 93.66%, purity after HPLC detection: 99.46%.

Embodiment 2

[0027] Add 100ml ethylbenzene, 10g (0.034mol) 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinemethanol (N7) and 10.92g (0.061mol) NBS in the reaction flask, under nitrogen protection Under the condition of stirring, the temperature was raised to 80°C, and the heat preservation reaction was carried out for 4 hours to prepare the intermediate product compound N8.1, without separation, 17.88g (0.068mol) triphenylphosphine was directly added to the obtained reaction solution, and the temperature was raised to 120°C with stirring. ℃, heat preservation reaction for 4 hours, then lower the temperature to 10 ℃, stir and crystallize for 2 hours, centrifuge, and dry to obtain 19.19g of product [[2-cyclopropyl-4-(4-fluorophenyl)-3-quinoline Base] methyl] triphenylphosphorous chloride (N8.2), yield 91.00%, purity after HPLC detection: 99.23%.

Embodiment 3

[0029] Add 50ml xylene (a mixture of o-paraxylene), 10g (0.034mol) 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinemethanol (N7) and 6.68g (0.0375mol) NBS, under the condition of nitrogen protection, stir and heat up to 60 ° C, and keep the temperature for 8 hours to prepare the intermediate product compound N8.1, without separation, directly add 11.62g (0.044mol) to the obtained reaction solution Triphenylphosphine, stir and heat up to 90°C, heat preservation reaction for 8 hours, then lower the temperature to 0°C, stir and crystallize for 1 hour, centrifuge, and dry to obtain 19.26g of product [[2-cyclopropyl-4-(4- Fluorophenyl)-3-quinolinyl]methyl]triphenylphosphine chloride (N8.2), yield 91.34%, purity after HPLC detection: 99.38%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of a pitavastatin calcium intermediate, which comprises the following steps: (1) under the protection of nitrogen, carrying out chemical reaction on compounds N7 and NBS and a solvent at 30-80 DEG C to prepare an intermediate product compound N8.1, and (2) adding triphenylphosphine into the reaction solution obtained in the step (1), heating to 60-120DEG C for reaction, cooling to 0-20 DEG C for stirring crystallization after the reaction is finished, and filtering to obtain a compound N8.2, wherein the specific synthetic route is as follows. Thepreparation method has the advantages of mild reaction conditions, no generation of a large amount of bromine-containing and phosphorus-containing wastewater in the reaction process, no influences ofacids and bases on the intermediate product compound N8.1, and difficult decomposition, so the yield of the target product is high and reaches 90% or above, the purity is high and reaches 99% or above, and the product has the advantages of simple post-treatment, greenness and environmental protection, and suitableness for industrial production.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical synthesis, in particular to a pitavastatin calcium intermediate [[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]methyl]triphenyl bromide Phosphorus preparation method. Background technique [0002] Pitavastation calcium (Pitavastation, NK-104), the first fully synthetic HMG-CoA reductase inhibitor jointly developed by Nissan Chemical and Kowa Co., Ltd. Inhibition of a liver enzyme called HMGCo-A reductase to reduce the ability of the liver to produce cholesterol, thereby improving elevated blood cholesterol levels, is mainly used to treat patients with hypercholesterolemia and familial hypercholesterolemia, because it reduces Lipids work so well that they have been dubbed "super statins." [0003] Among them, the compound [[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]methyl]triphenylphosphonium bromide is one of the important intermediates for preparing pitavastatin calcium. Chinese patent...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07F9/60
CPCC07F9/60
Inventor 陈本顺李大伟张维冰徐春涛马骧钱若灿张凌怡程毅叶金星何义万新强
Owner 江苏阿尔法集团福瑞药业(宿迁)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products